Maxim initiated coverage of Mainz Biomed (MYNZ) with a Buy rating and $14 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MYNZ: Mainz Biomed, GANZIMMUN launch enhanced ColoAlert CRC screening test Mainz Biomed Regains Nasdaq Listing Compliance Mainz Biomed regains compliance with Nasdaq Capital Market Mainz Biomed initiates U.S. study to evaluate CRC test Mainz Biomed NV trading resumes
